Inability to Tolerate Standard Therapy Is a Major Reason for Poor Outcome In Older Adults with Acute Lymphoblastic Leukemia (ALL): Results From the International MRC/ECOG Trial
Year: 2010
Type: article
Source: Blood
Institutions: University College Hospital, University of Oxford, University College London, University Hospitals of Cleveland, University Hospitals Cleveland Medical Center, Mayo Clinic, University of Pennsylvania, University Hospitals Bristol NHS Foundation Trust, Nottingham City Hospital, Technion – Israel Institute of Technology, Rambam Health Care Campus, Memorial Sloan Kettering Cancer Center
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2524030616
